Role of Gray Scale and Doppler Ultrasound Scoring in Predicting the Severity of Placenta Accreta Spectrum in High Risk Pregnancies

Authors

  • Naila Mumtaz PNS Shifa / BUHSC, Karachi
  • Usman Shakil PNS Shifa / BUHSC, Karachi
  • Sohaila Sarwat PNS Shifa / BUHSC, Karachi
  • Shazia Alam PNS Shifa / BUHSC, Karachi
  • Syed Uzair Maqsood Medicare Cardiac and General Hospital, Karachi
  • Syed Umair Bin Uzair Dow Medical College, Karachi

DOI:

https://doi.org/10.36283/ziun-pjmd14-4/060

Abstract

Background: Despite advancements in imaging, the subjectivity of ultrasonography (USG) interpretation and lack of standardized scoring systems contribute to underdiagnosis or overdiagnosis of placenta accreta spectrum (PAS).

Objectives: To evaluate the diagnostic accuracy of SG scoring systems in predicting PAS and to correlate these scores with intraoperative findings in patients undergoing cesarean delivery.

Methods: This cross-sectional study, conducted at the Department of Radiology, PNS Shifa, Karachi, Pakistan, from October 2024 to March 2025, evaluated the diagnostic accuracy of USG scoring in predicting PAS and its correlation with intraoperative findings. A sample of 61 high-risk pregnant women with prior cesarean sections and suspected PAS was included using non-probability, consecutive sampling technique. Gestational age, placental location, retroplacental myometrial thickness, bladder wall integrity, vascular lacunae, and traversing vessels were assessed via gray-scale and doppler USG. A structured scoring system classified PAS severity: scores 5–10 indicated accreta/increta, >10 indicated percreta, and <5 indicated no PAS. Intraoperative findings confirmed PAS diagnosis. Data were analyzed using IBM-SPSS Statistics, version 26.0. P<0.05 was taken significant.

Results: The mean gestational age at delivery was 34.12±2.54 weeks, with 88.5% (n=54) delivering preterm. PAS was identified in 23.0% (n=14) via USG and 21.3% (n=13) intraoperatively. USG scoring system demonstrated sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy as 100%, 97.9%, 92.9%, 100%, and 98.4% respectively. ROC analysis showed excellent performance (AUC=0.990, p<0.001), with perfect classification for percreta (AUC=1.00, p<0.001).

Conclusion: This study confirms that ultrasound scoring is a highly accurate and reliable tool for diagnosing PAS.

Author Biographies

  • Naila Mumtaz, PNS Shifa / BUHSC, Karachi

    Department of Radiology

  • Usman Shakil, PNS Shifa / BUHSC, Karachi

    Department of Radiology

  • Sohaila Sarwat, PNS Shifa / BUHSC, Karachi

    Department of Radiology

  • Shazia Alam, PNS Shifa / BUHSC, Karachi

    Department of Radiology

  • Syed Uzair Maqsood, Medicare Cardiac and General Hospital, Karachi

    Department of Pediatrics

  • Syed Umair Bin Uzair, Dow Medical College, Karachi

    Department of Medicine

References

1. Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. Int J Womens Health. 2020 Dec;12:1033-1045. doi:10.2147/IJWH.S224191

2. Wekere FCC, Inimgba NM, Kua PL, Okagua KE, Asikimabo-Ofori S, Ocheche US, et al. Placenta Accreta Spectrum: Prevalence, Trend and Association with Sociodemographic / Obstetric Factors in a Tertiary Health Facility in Niger Delta, Nigeria. Niger Med J. 2023 Nov–Dec;63(6):467-473. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11170246/

3. Piñas Carrillo A, Chandraharan E. Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure. Womens Health (Lond). 2019 Sep;15:1745506519878081. doi:10.1177/1745506519878081

4. Tavcar J, Movilla P, Carusi DA, Loring M, Reddy H, Isaacson K, et al. Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome. J Minim Invasive Gynecol. 2023 May–Jun;30(3):192-198. doi:10.1016/j.jmig.2022.11.013

5. Majid E, Kulsoom S, Fatima S, Zuberi BF. To evaluate rising caesarean section rate and factors contributing to it by using Modified Robson's Criteria at a tertiary care hospital. Pak J Med Sci. 2022 Oct;38(7):2021-2025. doi:10.12669/pjms.38.7.5983

6. Üstünyurt E. Local uterine resection with Bakri balloon placement in placenta accreta spectrum disorders. Turk J Obstet Gynecol. 2020 Jun;17(2):108-114. doi:10.4274/tjod.galenos.2020.82652

7. Wu X, Yang H, Yu X, Zeng J, Qiao J, Qi H, et al. The prenatal diagnostic indicators of placenta accreta spectrum disorders. Heliyon. 2023 May;9(5):e16241. doi:10.1016/j.heliyon.2023.e16241

8. Tadayon M, Javadifar N, Dastoorpoor M, Shahbazian N. Frequency, Risk Factors, and Pregnancy Outcomes in Cases with Placenta Accreta Spectrum Disorder: A Case-Control Study. J Reprod Infertil. 2022 Oct–Dec;23(4):279-287. doi:10.18502/jri.v23i4.10814

9. Kayem G, Seco A, Vendittelli F, Crenn Hebert C, Dupont C, Branger B, et al. Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study. Sci Rep. 2024 Jan;14(1):6564. doi:10.1038/s41598-024-56964-9

10. Cali G, Forlani F, Timor-Trisch I, Palacios-Jaraquemada J, Foti F, Minneci G, et al. Diagnostic accuracy of ultrasound in detecting the depth of invasion in women at risk of abnormally invasive placenta: A prospective longitudinal study. Acta Obstet Gynecol Scand. 2018 Oct;97(10):1219-1227. doi:10.1111/aogs.13389

11. Adu-Bredu TK, Rijken MJ, Nieto-Calvache AJ, Stefanovic V, Aryananda RA, Fox KA, et al. A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource limited settings. Int J Gynaecol Obstet. 2023 Mar;160(3):732-741. doi:10.1002/ijgo.14376

12. Arakaza A, Zou L, Zhu J. Placenta Accreta Spectrum Diagnosis Challenges and Controversies in Current Obstetrics: A Review. Int J Womens Health. 2023 Apr;15:635-654. doi:10.2147/IJWH.S395271

13. Del Negro V, Aleksa N, Galli C, Ciminello E, Derme M, Vena F, et al. Ultrasonographic Diagnosis of Placenta Accreta Spectrum (PAS) Disorder: Ideation of an Ultrasonographic Score and Correlation with Surgical and Neonatal Outcomes. Diagnostics (Basel). 2020 Jan;11(1):23. doi:10.3390/diagnostics11010023

14. Zhang J, Li H, Feng D, Wu J, Wang Z, Feng F. Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum. BMC Pregnancy Childbirth. 2023 Jan;23(1):569. doi:10.1186/s12884-023-05886-x

15. Vimercati A, Galante A, Fanelli M, Cirignaco F, Vitagliano A, Nicolì P, et al. PAS or Not PAS? The Sonographic Assessment of Placenta Accreta Spectrum Disorders and the Clinical Validation of a New Diagnostic and Prognostic Scoring System. J Imaging. 2024 Dec;10(12):315. doi:10.3390/jimaging10120315

16. Agarwal N, Hernandez-Andrade E, Sibai BM, Amro FH, Coselli JO, Bartal MF, et al. Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system. Am J Obstet Gynecol MFM. 2024 Oct;6(10):101451. doi:10.1016/j.ajogmf.2024.101451

17. Chen L, Shi HF, Jiang H, Shi XM, Wang YY, Zhang AQ, et al. Correlation of An Ultrasonic Scoring System and Intraoperative Blood Loss in Placenta Accreta Spectrum Disorders: A Retrospective Cohort Study. Biomed Environ Sci. 2021 Mar;34(2):163-169. doi:10.3967/bes2021.022

18. Hessami K, Horgan R, Munoz JL, Norooznezhad AH, Nassr AA, Fox KA, et al. Trimester-specific diagnostic accuracy of ultrasound for detection of placenta accreta spectrum: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024 Jun;63(6):723-730. doi:10.1002/uog.27606

19. Peng X, Tan X, Wu Z. Prenatal ultrasound scoring in diagnosis and postpartum outcomes prediction for Placenta Accreta Spectrum (PAS): a systematic review. BMC Pregnancy Childbirth. 2024 Jan;24(1):846. doi:10.1186/s12884-024-07076-9

20. Alves ÁLL, Silva LBD, Costa FDS, Rezende GC. Management of placenta accreta spectrum. Rev Bras Ginecol Obstet. 2021 Sep;43(9):713-723. doi:10.1055/s-0041-1736371

21. Liu H, Zhang B, Wang W, Li H, Huang X, Wang J, et al. Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum. BMC Pregnancy Childbirth. 2023 Jan;23(1):406. doi:10.1186/s12884-023-05736-w

22. Chen Q, Shen K, Wu Y, Wei J, Huang J, Pei C. Advances in Prenatal Diagnosis of Placenta Accreta Spectrum. Medicina (Kaunas). 2025 Mar;61(3):392. doi:10.3390/medicina61030392

23. Nguyen VH, Huynh QH, Ha TN, Nguyen MCN, Nguyen PN. Additional Role of Magnetic Resonance Imaging to Ultrasound in Assessing Placenta Accreta Spectrum Disorders: A Retrospective Cross-sectional Study from Vietnam. Oman Med J. 2024 Nov–Dec;39(6):e697. doi:10.5001/omj.2024.119

24. Gulati A, Anand R, Aggarwal K, Agarwal S, Tomer S. Ultrasound as a Sole Modality for Prenatal Diagnosis of Placenta Accreta Spectrum: Potentialities and Pitfalls. Indian J Radiol Imaging. 2021 Jul–Sep;31(3):527-538. doi:10.1055/s-0041-1735864

25. Einerson BD, Gilner JB, Zuckerwise LC. Placenta Accreta Spectrum. Obstet Gynecol. 2023 Jul;142(1):31-50. doi:10.1097/AOG.0000000000005229

Downloads

Published

2025-09-29

Metrics

How to Cite

1.
Mumtaz N, Shakil U, Sarwat S, Alam S, Maqsood SU, Uzair SUB. Role of Gray Scale and Doppler Ultrasound Scoring in Predicting the Severity of Placenta Accreta Spectrum in High Risk Pregnancies. PJMD [Internet]. 2025 Sep. 29 [cited 2026 Jun. 23];14(4). Available from: https://ojs.zu.edu.pk/pjmd/article/view/3817